Education
About Us
Working with TipRanks
Follow Us
Kathleen Sebelius Insider Profile
4 Followers
Kathleen Sebelius, Director at Dermira, holds 6.00K shares in Dermira (Ticker: ~DERM), holds 91.21K shares in Humacyte (Ticker: HUMA), holds 31.89K shares in Exact Sciences (Ticker: EXAS). Most recently, Kathleen Sebelius ― shares of Dermira on ― for an estimated value of ―.
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+91.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Kathleen Sebelius holds in companies
Most Profitable Insider Trade
The most profitable trade made by Kathleen Sebelius
Kathleen Sebelius's Trading History
Dermira
―
―
―
$112.50K
Myovant Sciences
Jun 14, 2019
―
Informative Buy
44.78K
$134.90K
Exact Sciences
Jun 17, 2024
Director
Uninformative Buy
―
$1.56M
Humacyte
Apr 08, 2025
Director
Informative Buy
66.00K
$243.52K
Journey Medical Corp
―
Director
―
$46.02K
List of latest transactions for each holding click on a transaction to see Kathleen Sebelius's performance on stock
You May Also Like
Kathleen Sebelius insider profile FAQ
What is the percentage of profitable transactions made by Kathleen Sebelius?
The percentage of profitable transactions made by Kathleen Sebelius is 100%.
What is the average return per transaction made by Kathleen Sebelius?
The average return per transaction made by Kathleen Sebelius is 91.90%.
What stocks does Kathleen Sebelius hold?
Kathleen Sebelius holds: ~DERM, MYOV, EXAS, HUMA, DERM stocks.
What was Kathleen Sebelius’s latest transaction?
Kathleen Sebelius latest transaction was an Uninformative Buy of ―.
What was Kathleen Sebelius's most profitable transaction?
Kathleen Sebelius’s most profitable transaction was an Informative Buy of HUMA stock on April 8, 2025. The return on the trade was 102.60%.
What is Kathleen Sebelius's role in Dermira?
Kathleen Sebelius's role in Dermira is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.